HCW Biologics Inc (NASDAQ:HCWB) does about 48.63K shares in volume on a normal day but saw 509820017 shares change hands in the recent trading day. The company now has a market cap of 44.70M USD. Its current market price is $1.24, marking an increase of 320.91% compared to the previous close of $0.29. The 52 week high reached by this stock is $1.93 whilst the lowest price level in 52 weeks is $0.28.
HCW Biologics Inc (HCWB) has a 20-day trading average at $0.4571 and the current price is -35.75% off the 52-week high compared with 349.11% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.5058 and its 200-day simple moving average is $0.9265. If we look at the stock’s price movements over the week, volatility stands at 48.17%, which decreases to 21.09% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 83.92 to suggest the stock is overbought.
The consensus objective for the share price is $3.00, suggesting that the stock has a potential upside of 58.67% over the period.
The current price level is 171.25%, 145.17%, and 33.84% away from its SMA20, SMA50, and SMA200 respectively, with the HCWB price moving below the 50-day SMA on current market day. HCW Biologics Inc (HCWB) stock is up 244.16% over the week and 138.42% over the past month. Its price is 1.22% year-to-date and -12.06% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/30/2024, with the company’s earnings per share (EPS) of -0.3 below consensus estimates by -0.15. The company’s next earnings report forecasts estimating quarterly EPS at -0.12 and -0.55 for whole year.
To reach the target analysts have set, the stock logically needs to grow 58.67 percent from here.
The company has a return on equity of -537.24%. The beta has a value of 0.77. Price to sales ratio is 12.77.
